3 results
Approved WMORecruiting
- To evaluate the treatment efficiency by time to progression according to RECIST 1.1
Approved WMOCompleted
Objective: Evaluation of safety and initial efficacy of a novel fusion-protein based anti-COVID19 vaccine in healthy volunteers.
Approved WMOPending
To find a suitable treatment option for the 25% of HS patients who are therapy-resistant. Additionally, we expect a faster healing time of the wounds, meaning that even if patients respond to current treatment, HBOT may improve their quality of lifeā¦